<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H978C1E48056A4180903A793A8EF9D570" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2463 IH: DROP Act of 2015</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-20</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2463</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150520">May 20, 2015</action-date> 
<action-desc><sponsor name-id="B001287">Mr. Bera</sponsor> (for himself and <cosponsor name-id="R000582">Mr. Roe of Tennessee</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on the <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To authorize the Attorney General to provide grants for drug disposal sites.</official-title> 
</form> 
<legis-body id="H9406CDC00E804FE3BB8F7A5C45735195" style="OLC"> 
<section id="H9B574DE4540143BAB48C5CAE6D3AFF0A" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Dispose Responsibly of your Pills Act of 2015</short-title></quote> or <quote>DROP Act of 2015</quote>. </text></section> <section id="H2A2C85C9D1D94A7BAE6902E5FAAC66DD"><enum>2.</enum><header>Grants for drug disposal sites</header> <subsection id="H3A8C2A1DD07840D4BBC9F5ABBE642DCB"><enum>(a)</enum><header>Program authorized</header><text>The Attorney General, in coordination with the Administrator of the Drug Enforcement Administration, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, may make grants to eligible entities to expand or make available disposal sites for unwanted prescription medications.</text></subsection> 
<subsection id="H0986183BB1CF4B45B104D4A70E1EB972"><enum>(b)</enum><header>Application</header> 
<paragraph id="H51A98E09B92B4C4EAEBA4912E0168FCD"><enum>(1)</enum><header>In general</header><text>An eligible entity desiring a grant under this section shall submit an application to the Attorney General—</text> <subparagraph id="H54947103BC434E0080689FA50FCD9BF8"><enum>(A)</enum><text>that meets the criteria under paragraph (2); and</text></subparagraph> 
<subparagraph id="H893397FEA9404D4B9F544C1056084A06"><enum>(B)</enum><text>at such time, in such manner, and accompanied by such information as the Attorney General may require.</text></subparagraph></paragraph> <paragraph id="H1952BB2236BC45439F493ADA87B6AD28"><enum>(2)</enum><header>Criteria</header><text>An eligible entity, in submitting an application under paragraph (1), shall—</text> 
<subparagraph id="H307F0DFDE83841269C40C65612FB27B0"><enum>(A)</enum><text>describe the evidence-based methodology and outcome measurements that will be used to evaluate the program funded with a grant under this section, and specifically explain how such measurements will provide valid measures of the impact of the program;</text></subparagraph> <subparagraph id="H717870816F4B48AEBC9E377FA51721FA"><enum>(B)</enum><text>describe how the program could be broadly replicated if demonstrated to be effective; and</text></subparagraph> 
<subparagraph id="HA841C7E31954437CB209EDD0CDCFD1A2"><enum>(C)</enum><text>identify the governmental and community agencies that will coordinate the program.</text></subparagraph></paragraph></subsection> <subsection id="HB81A0CD5F5024C55942FFB1D658BD083"><enum>(c)</enum><header>Use of funds</header><text>An eligible entity shall use a grant received under this section for—</text> 
<paragraph id="H4F849AF8461B4688AB1AFEA258C39B95"><enum>(1)</enum><text>expenses of a prescription drug disposal site, including materials and resources;</text></paragraph> <paragraph id="H5D6E5C935E164F8CA68B8D6548801081"><enum>(2)</enum><text>implementing disposal procedures and processes;</text></paragraph> 
<paragraph id="H46B526F4C5E14ECB996CE9ED4F009089"><enum>(3)</enum><text>implementing community education strategies, including community education materials and resources;</text></paragraph> <paragraph id="H3112CE9F62844979A1C87B9F9635B917"><enum>(4)</enum><text>replicating a prescription drug take back initiative throughout multiple jurisdictions; and</text></paragraph> 
<paragraph id="HF11FB3111BD84E37B233367F7FA4D472"><enum>(5)</enum><text>training of law enforcement officers and other community participants.</text></paragraph></subsection> <subsection id="H2D964013B0C840FCA63FF70811A92050"><enum>(d)</enum><header>Grant amounts and duration</header> <paragraph id="HDB2864345D2D4F29AF5F23040C8ECB8E"><enum>(1)</enum><header>Maximum amount</header><text>The Attorney General may not award a grant under this section in an amount that exceeds $250,000.</text></paragraph> 
<paragraph id="H1284012F1F564008A81B72128C9FA24D"><enum>(2)</enum><header>Duration</header><text>The Attorney General shall award grants under this section for a period not to exceed 2 years.</text></paragraph></subsection> <subsection id="HD176C2DBB0F9400085625D16AA5462D8"><enum>(e)</enum><header>Technical assistance grant</header><text>The Attorney General shall make a grant to provide technical assistance and training for an eligible entity receiving a grant under this section.</text></subsection> 
<subsection id="HD408BDEEB3CF49D78C8F380796E34A99"><enum>(f)</enum><header>Evaluation</header> 
<paragraph id="HC15CC8B388EF40C9BC152C3FB593DA01"><enum>(1)</enum><header>In general</header><text>The Attorney General shall make a grant for evaluation of the performance of each eligible entity receiving a grant under this section.</text></paragraph> <paragraph id="H9D683495ABB9426FB9FF09E1322F9E1C"><enum>(2)</enum><header>Reports</header><text>Each fiscal year, the recipient of a grant under this subsection shall submit to the Attorney General a report that evaluates—</text> 
<subparagraph id="H74716ECCDE63472DBEAD0E1F3C4E2FD5"><enum>(A)</enum><text>the effectiveness of the prescription drug take back program of each eligible entity receiving a grant under this section; and</text></subparagraph> <subparagraph id="HF9D219E6E99E4EC894D12DB32B5A959F"><enum>(B)</enum><text>the effect of disposal efforts on drug circulation.</text></subparagraph></paragraph> 
<paragraph id="H8E37480E8F774F1CB644BA1FEC46B8EA"><enum>(3)</enum><header>Public Availability</header><text>The Attorney General shall make the reports submitted under paragraph (2) publicly available on the public Internet website of the Attorney General. </text></paragraph></subsection> <subsection id="H608C5F0943AF434EA836EDF9508C19DE"><enum>(g)</enum><header>Authorization of appropriations</header><text>There are authorized to be appropriated to carry out this section $2,500,000 for each of fiscal years 2016 through 2020.</text></subsection> 
<subsection id="H9D076FFACCAC40CDB1151BD69891811E"><enum>(h)</enum><header>Definition of eligible entity</header><text>In this section, the term <quote>eligible entity</quote> means—</text> <paragraph id="H3F2E91F35EAE40BC9D96E96516B70727"><enum>(1)</enum><text>a State, local, or tribal law enforcement agency;</text></paragraph> 
<paragraph id="H8567F2E98D97489EADB7C3FC4A8723B3"><enum>(2)</enum><text>a manufacturer, distributor, or reverse distributor of prescription medications;</text></paragraph> <paragraph id="HD04796C831214DB4824490BC68B522A6"><enum>(3)</enum><text>a retail pharmacy;</text></paragraph> 
<paragraph id="H78BF411356F54C55872145F1822BE179"><enum>(4)</enum><text>a registered narcotic treatment program;</text></paragraph> <paragraph id="HD83C2037CD9E4597AA5668F3BA612454"><enum>(5)</enum><text>a hospital or clinic with an on-site pharmacy;</text></paragraph> 
<paragraph id="HF1C944295C58420BBEA8643200078C11"><enum>(6)</enum><text>an eligible long-term care facility; or</text></paragraph> <paragraph id="H173DE75983374EDFAEA52DAE69162980"><enum>(7)</enum><text>any other entity authorized by the Drug Enforcement Administration to dispose of prescription medications.</text></paragraph></subsection></section> 
</legis-body> 
</bill> 


